Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity

Immunity

Volumn 19, Issue 3, 2003, Pages 437-450

  Hanada, Toshikatsu ^a,b   Yoshida, Hiroki ^a,c   Kato, Seiya ^d   Tanaka, Kentaro ^a   Masutani, Kohsuke ^e   Tsukada, Jun ^f   Nomura, Yoshio ^b   Mimata, Hiromitsu ^b   Kubo, Masato ^f   Yoshimura, Akihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b OITA UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d KURUME UNIVERSITY   (Japan)

^e KYUSHU UNIVERSITY   (Japan)

^f TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; AUTOANTIBODY; GAMMA INTERFERON; INTERLEUKIN 4; PROTEIN BAFF; REGULATOR PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BIOACCUMULATION; CELL ACTIVATION; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SPLEEN; T LYMPHOCYTE; THYMUS;

EID: 10744223505     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(03)00240-1     Document Type: Article

References (45)

1. Alexander W.S., Starr R., Fenner J.E., Scott C.L., Handman E., Sprigg N.S., Corbin J.E., Cornish A.L., Darwiche R., Owczarek C.M.et al. SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell. 98:1999;597-608.
2. Arce E., Jackson D.G., Gill M.A., Bennett L.B., Banchereau J., Pascual V. Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus. J. Immunol. 167:2001;2361-2369.
3. Atsumi T., Ishihara K., Kamimura D., Ikushima H., Ohtani T., Hirota S., Kobayashi H., Park S.J., Saeki Y., Kitamura Y.et al. A point mutation of Tyr-759 in interleukin 6 family cytokine receptor subunit gp130 causes autoimmune arthritis. J. Exp. Med. 196:2002;979-990.
4. Balomenos D., Rumold R., Theofilopoulos A.N. Interferon-γ is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J. Clin. Invest. 101:1998;364-371.
5. Blanco P., Palucka A.K., Gill M., Pascual V., Banchereau J. Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus. Science. 294:2001;1540-1543.
6. Cella M., Jarrossay D., Facchetti F., Alebardi O., Nakajima H., Lanzavecchia A., Colonna M. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5:1999;919-923.
7. Chan O.T., Madaio M.P., Shlomchik M.J. The central and multiple roles of B cells in lupus pathogenesis. Immunol. Rev. 169:1999;107-121.
8. Chong M.M., Cornish A.L., Darwiche R., Stanley E.G., Purton J.F., Godfrey D.I., Hilton D.J., Starr R., Alexander W.S., Kay T.W. Suppressor of cytokine signaling-1 is a critical regulator of interleukin-7-dependent CD8+ T cell differentiation. Immunity. 18:2003;475-487.
9. Christensson B., Biberfeld P., Matell G. B-cell compartment in the thymus of patients with myasthenia gravis and control subjects. Ann. N Y Acad. Sci. 540:1988;293-297.
10. Fujimoto M., Naka T., Nakagawa R., Kawazoe Y., Morita Y., Tateishi A., Okumura K., Narazaki M., Kishimoto T. Defective thymocyte development and perturbed homeostasis of T cells in STAT-induced STAT inhibitor-1/suppressors of cytokine signaling-1 transgenic mice. J. Immunol. 165:2000;1799-1806.
11. Fukao T., Tanabe M., Terauchi Y., Ota T., Matsuda S., Asano T., Kadowaki T., Takeuchi T., Koyasu S. PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat. Immunol. 3:2002;875-881.
12. Graninger W.B., Hassfeld W., Pesau B.B., Machold K.P., Zielinski C.C., Smolen J.S. Induction of systemic lupus erythematosus by interferon-γ in a patient with rheumatoid arthritis. J. Rheumatol. 18:1991;1621-1622.
13. Gross J.A., Johnston J., Mudri S., Enselman R., Dillon S.R., Madden K., Xu W., Parrish-Novak J., Foster D., Lofton-Day C.et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature. 404:2000;995-999.
14. Haas C., Ryffel B., Hir L.M. IFN-γ receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice. J. Immunol. 160:1998;3713-3718.
15. Hanada T., Yoshida T., Kinjyo I., Minoguchi S., Yasukawa H., Kato S., Mimata H., Nomura Y., Seki Y., Kubo M.et al. A mutant form of JAB/SOCS1 augments the cytokine-induced JAK/STAT pathway by accelerating degradation of wild-type JAB/CIS family proteins through the SOCS-box. J. Biol. Chem. 276:2001;40746-40754.
16. + dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC. J. Exp. Med. 193:2001;1393-1402.
17. Kayagaki N., Yan M., Seshasayee D., Wang H., Lee W., French D.M., Grewal I.S., Cochran A.G., Gordon N.C., Yin J.et al. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-κB2. Immunity. 17:2002;515-524.
18. Kinjyo I., Hanada T., Inagaki-Ohara K., Mori H., Aki D., Ohishi M., Yoshida H., Kubo M., Yoshimura A. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity. 17:2002;583-591.
19. Litinskiy M.B., Nardelli B., Hilbert D.M., He B., Schaffer A., Casali P., Cerutti A. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3:2002;822-829.
20. Lutz M.B., Kukutsch N., Ogilvie A.L., Rossner S., Koch F., Romani N., Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods. 223:1999;77-92.
21. MacLennan I., Vinuesa C. Dendritic cells, BAFF, and APRIL. innate players in adaptive antibody responses Immunity. 17:2002;235-238.
22. Mackay F., Browning J.L. Baff. a fundamental survival factor for b cells Nat. Rev. Immunol. 2:2002;465-475.
23. Mahnke K., Schmitt E., Bonifaz L., Enk A.H., Jonuleit H. Immature, but not inactive. the tolerogenic function of immature dendritic cells Immunol. Cell Biol. 80:2002;477-483.
24. Marine J.C., McKay C., Wang D., Topham D.J., Parganas E., Nakajima H., Pendeville H., Yasukawa H., Sasaki A., Yoshimura A.et al. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell. 98:1999;609-616.
25. Metcalf D., Mifsud S., Di Rago L., Nicola N.A., Hilton D.J., Alexander W.S. Polycystic kidneys and chronic inflammatory lesions are the delayed consequences of loss of the suppressor of cytokine signaling-1 (SOCS-1). Proc. Natl. Acad. Sci. USA. 99:2002;943-948.
26. Miyamoto A., Nakayama K., Imaki H., Hirose S., Jiang Y., Abe M., Tsukiyama T., Nagahama H., Ohno S., Hatakeyama S.et al. Increased proliferation of B cells and auto-immunity in mice lacking protein kinase C-delta. Nature. 416:2002;865-869.
27. Moore P.A., Belvedere O., Orr A., Pieri K., LaFleur D.W., Feng P., Soppet D., Charters M., Gentz R., Parmelee D.et al. Blys. member of the tumor necrosis factor family and b lymphocyte stimulator Science. 285:1999;260-263.
28. Nagai H., Kim Y.S., Konishi N., Baba M., Kubota T., Yoshimura A., Emi M. Combined hypermethylation and chromosome loss associated with inactivation of SSI-1/SOCS-1/JAB gene in human hepatocellular carcinomas. Cancer Lett. 186:2002;59-65.
29. Naka T., Tsutsui H., Fujimoto M., Kawazoe Y., Kohzaki H., Morita Y., Nakagawa R., Narazaki M., Adachi K., Yoshimoto T.et al. SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-γ and IL-4 signaling in vivo. Immunity. 14:2001;535-545.
30. Nakagawa R., Naka T., Tsutsui H., Fujimoto M., Kimura A., Abe T., Seki E., Sato S., Takeuchi O., Takeda K.et al. SOCS-1 participates in negative regulation of LPS responses. Immunity. 17:2002;677-687.
31. Odendahl M., Jacobi A., Hansen A., Feist E., Hiepe F., Burmester G.R., Lipsky P.E., Radbruch A., Dorner T. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J. Immunol. 165:2000;5970-5979.
32. Palucka A.K., Banchereau J., Blanco P., Pascual V. The interplay of dendritic cell subsets in systemic lupus erythematosus. Immunol. Cell Biol. 80:2002;484-488.
33. Peng S.L., Moslehi J., Craft J. Roles of interferon-γ and interleukin-4 in murine lupus. J. Clin. Invest. 99:1997;1936-1946.
34. Ronnblom L.E., Alm G.V., Oberg K.E. Possible induction of systemic lupus erythematosus by interferon-α treatment in a patient with a malignant carcinoid tumour. J. Intern. Med. 227:1990;207-210.
35. Saha B., Harlan D.M., Lee K.P., June C.H., Abe R. Protection against lethal toxic shock by targeted disruption of the CD28 gene. J. Exp. Med. 183:1996;2675-2680.
36. Sakamoto H., Yasukawa H., Masuhara M., Tanimura S., Sasaki A., Yuge K., Ohtsubo M., Ohtsuka A., Fujita T., Ohta T.et al. A Janus kinase inhibitor, JAB, is an interferon-γ-inducible gene and confers resistance to interferons. Blood. 92:1998;1668-1676.
37. Schwarting A., Wada T., Kinoshita K., Tesch G., Kelley V.R. IFN-γ receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. J. Immunol. 161:1998;494-503.
38. Seery J.P., Carroll J.M., Cattell V., Watt F.M. Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon γ in the epidermis. J. Exp. Med. 186:1997;1451-1459.
39. Shouda T., Yoshida T., Hanada T., Wakioka T., Oishi M., Miyoshi K., Komiya S., Kosai K., Hanakawa Y., Hashimoto K.et al. Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J. Clin. Invest. 108:2001;1781-1788.
40. Siegal F.P., Kadowaki N., Shodell M., Fitzgerald-Bocarsly P.A., Shah K., Ho S., Antonenko S., Liu Y.J. The nature of the principal type 1 interferon-producing cells in human blood. Science. 284:1999;1835-1837.
41. Steinman R.M., Nussenzweig M.C. Avoiding horror autotoxicus. the importance of dendritic cells in peripheral T cell tolerance Proc. Natl. Acad. Sci. USA. 99:2002;351-358.
42. Usui T., Yoshioka H., Ko K., Sung M.E., Nagata N., Okamoto T., Ohshio G., Kita T., Inada M. Age associated changes in the distribution of lpr gene-induced B220-positive T cells in lymphoid organs of MRL/Mp-lpr/lpr mice using dual exposure microphotographs of double immunofluorescence staining. Biotech. Histochem. 71:1996;182-189.
43. Wakeland E.K., Liu K., Graham R.R., Behrens T.W. Delineating the genetic basis of systemic lupus erythematosus. Immunity. 15:2001;397-408.
44. Yasukawa H., Misawa H., Sakamoto H., Masuhara M., Sasaki A., Wakioka T., Ohtsuka S., Imaizumi T., Matsuda T., Ihle J.N.et al. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 18:1999;1309-1320.
45. Yoshikawa H., Matsubara K., Qian G.S., Jackson P., Groopman J.D., Manning J.E., Harris C.C., Herman J.G. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat. Genet. 28:2001;29-35.